Chronic Renal Failure: Clinical Trials

2 trials for Chronic Renal Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Withdrawn 2

Follow Chronic Renal Failure: new trials by email Literature Review of Chronic Renal Failure trials Research Report on Chronic Renal Failure

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
Best Practice, Tocilizumab - Cerebrovascular Accident, Chronic Obstructive Pulmonary Disease
Phase 3WithdrawnEmory University2020-04-072020-06-18
Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs
Pancreatic enzimes, Creon ® - Chronic Renal Failure
Phase 3WithdrawnAzidus Brasil2007-06-012022-11-03

Narrower conditions

Kidney Failure, Chronic (2)  ·  COVID-19 (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus (1)  ·  Neoplasms (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Stroke (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Renal Insufficiency (2)  ·  Renal Insufficiency, Chronic (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Brain Diseases (1)

Interventions

Disulfides (1)  ·  Immunoglobulin G (1)  ·  Practice Guidelines as Topic (1)  ·  Standard of Care (1)  ·  tocilizumab (1)

Sponsors

Azidus Brasil (1)  ·  Emory University (1)

Countries

Brazil (1)  ·  United States (1)

Top investigators

Ajay K Nooka (1)  ·  Alexandre Frederico, Doctor (1)

NIH funding

P30CA138292 (1)